FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.
The National Bureau of Economic Research's Assessing the US Medical Innovation System grant supports research on how policies and stakeholders shape medical innovation and its health impacts in the US.
Investigator Initiated Research Program supports Michigan investigators conducting evidence-based health studies and testing interventions to improve health outcomes, care quality, and healthcare access.
Science and Global Health R&D supports researchers and organizations developing biomedical research and new health tools to address neglected challenges and improve global health cost-effectively.